| NCT01173887 | Kyowa Kirin Co., Ltd. | Adult T-cell Leukemia-Lymphoma | 2010-07 | PHASE2 |
| NCT03191526 | Kyowa Kirin Co., Ltd. | HTLV-1 Associated Myelopathy | 2017-05-22 | PHASE3 |
| NCT01728805 | Kyowa Kirin, Inc. | Cutaneous T-Cell Lymphoma | 2012-11 | PHASE3 |
| NCT01192984 | Kyowa Kirin Co., Ltd. | Peripheral T+NK-cell Lymphoma | 2010-09 | PHASE2 |
| NCT01226472 | Kyowa Kirin Co., Ltd.|Kyowa Hakko Kirin Pharma, Inc. | Peripheral T-cell Lymphoma|Cutaneous T-cell Lymphoma | 2010-08 | PHASE2 |
| NCT02444793 | Pfizer|Kyowa Kirin Co., Ltd. | Advanced+Metastatic Solid Tumors | 2015-05 | PHASE1 |
| NCT00920790 | Kyowa Kirin Co., Ltd. | Adult T-cell Leukemia-lymphoma | 2009-06 | PHASE2 |
| NCT01626664 | Kyowa Kirin, Inc. | Adult T-cell Leukemia-Lymphoma | 2012-06 | PHASE2 |
| NCT01611142 | Kyowa Kirin Co., Ltd.|Kyowa Hakko Kirin Pharma, Inc. | Peripheral T-Cell Lymphoma | 2012-04 | PHASE2 |
| NCT00355472 | Kyowa Kirin Co., Ltd. | Adult T-Cell Leukemia and Lymphoma (ATL)|Adult Peripheral T-Cell Lymphoma (PTCL) | 2007-02 | PHASE1 |
| NCT02358473 | Kyowa Kirin, Inc. | Non-Small Cell Lung Cancer | 2015-01 | PHASE1 |
| NCT04930653 | City of Hope Medical Center|National Cancer Institute (NCI) | Folliculotropic Mycosis Fungoides|Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Sezary Syndrome|Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8|Transformed Mycosis Fungoides | 2022-10-19 | PHASE2 |
| NCT05996185 | Yale University|Kyowa Kirin, Inc. | T Cell Lymphoma|T-cell Lymphoma | 2024-10-09 | PHASE2 |
| NCT05414500 | University of Alabama at Birmingham|Seagen Inc.|Kyowa Kirin, Inc. | Cutaneous T Cell Lymphoma|Mycosis Fungoides | 2023-05-01 | PHASE1 |
| NCT06698003 | Memorial Sloan Kettering Cancer Center | T-Cell Leukemia+Lymphoma, Adult|T-cell Leukemia+Lymphoma|T-cell Leukemia|Lymphoma | 2024-11-15 | PHASE2 |
| NCT05956041 | University of Michigan Rogel Cancer Center|Merck Sharp & Dohme LLC|Hoosier Cancer Research Network | Cutaneous T Cell Lymphoma|Fungoides Mycosis Sezary Syndrome | 2023-12-06 | PHASE2 |
| NCT02946671 | Osaka University|Kyowa Kirin Co., Ltd.|Ono Pharmaceutical Co., Ltd.|Clinical Study Support, Inc.|Fiverings Co., Ltd. | Gastric Cancer|Esophageal Cancer|Lung Cancer|Renal Cancer|Oral Cancer | 2016-03 | PHASE1 |
| NCT04848064 | John Reneau | Recurrent Adult T-Cell Leukemia+Lymphoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Refractory Adult T-Cell Leukemia+Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 2022-05-06 | PHASE1 |
| NCT04256018 | Stanford University | Sezary Syndrome|Mycosis Fungoides | 2020-03-30 | PHASE2 |
| NCT07529405 | Virogen Biotechnology Inc.|H. Lee Moffitt Cancer Center and Research Institute | Mycosis Fungoides | 2026-07-30 | PHASE2 |
| NCT04745234 | Kyowa Kirin, Inc. | Cutaneous T-Cell Lymphoma, Relapsed|Cutaneous T-Cell Lymphoma Refractory | 2021-08-16 | PHASE2 |
| NCT02301130 | Kyowa Kirin, Inc.|AstraZeneca | Advanced Solid Tumors | 2014-11-26 | PHASE1 |
| NCT04676087 | Emory University|National Cancer Institute (NCI) | Mycosis Fungoides|Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Sezary Syndrome | 2021-04-21 | PHASE1|PHASE2 |
| NCT04185220 | National Cancer Institute (NCI) | Adult T-Cell Lymphoma+Leukemia|Sezary Syndrome|Mycosis Fungoides | 2020-02-26 | PHASE1 |
| NCT02867007 | Kyowa Kirin, Inc. | Solid Tumor|Cancer|Carcinoma | 2016-08 | PHASE1 |
| NCT01929486 | Aichi Medical University | Solid Tumor | 2013-02 | PHASE1 |
| NCT03309878 | National Cancer Institute (NCI) | Recurrent Diffuse Large B-Cell Lymphoma|Recurrent High Grade B-Cell Lymphoma|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory High Grade B-Cell Lymphoma|Refractory Transformed B-Cell Non-Hodgkin Lymphoma | 2018-10-24 | PHASE1|PHASE2 |
| NCT04541017 | National Cancer Institute (NCI) | Mycosis Fungoides|Recurrent Mycosis Fungoides|Recurrent Mycosis Fungoides and Sezary Syndrome|Recurrent Sezary Syndrome|Refractory Mycosis Fungoides|Refractory Mycosis Fungoides and Sezary Syndrome|Refractory Sezary Syndrome|Sezary Syndrome|Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8 | 2021-04-06 | PHASE1|PHASE2 |
| NCT06285370 | Kyowa Kirin China Pharmaceutical Co., Ltd. | Cutaneous T-Cell Lymphoma | 2023-05-29 | PHASE4 |
| NCT02705105 | Kyowa Kirin, Inc.|Bristol-Myers Squibb | Solid Tumor|Cancer|Carcinoma|Hepatocellular Carcinoma|HCC | 2016-02 | PHASE1|PHASE2 |
| NCT04128072 | European Organisation for Research and Treatment of Cancer - EORTC | Stage IB-IIB Cutaneous T-Cell Lymphoma | 2023-03-07 | PHASE2 |